Search | SPORTIVO Network

rohit001 added blog Other
2026-06-24 11:49:26

Anthracycline-Based Oncology Drug Class Market Advances with Continued Role in Chemotherapy Regimens and Expanding Cancer Treatment Applications
According to the latest report published by Data Bridge Market Research, the Anthracycline-Based Oncology Drug Class Market The global anthracycline-based oncology drug class market size was valued at USD 5.40 billion in 2025 and is expected to reach USD 7.33 billion by 2033, at a CAGR of3.90% during the forecast period A talented team works strictly with their potential...

0 Comments 0 Shares 600 Views 0 Reviews

Please log in to like, share and comment!
amitpatil added blog Other
2025-11-18 06:51:38

High Potency API Market: Increasing Investments in Oncology Drugs and Specialized Manufacturing
According to a new report published by Introspective Market Research, titled, High Potency Active Pharmaceutical Ingredients Market by Type, Synthesis, and Application, The Global High Potency Active Pharmaceutical Ingredients Market Size Was Valued at USD 26.42 Billion in 2023 and is Projected to Reach USD 66.71 Billion by 2032, Growing at a CAGR of 10.84%. 2. Introduction / Market...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
rishika_2003 added blog Other
2026-03-13 06:56:39

Mantle Cell Lymphoma Therapeutics Market to Reach USD 2.78 Billion by 2034, Driven by Advances in Targeted Therapies and CAR-T Innovations
According to a new report from Intel Market Research, the global Mantle Cell Lymphoma Therapeutics market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.78 billion by 2034, growing at a steady CAGR of 7.8% during the forecast period (2026–2034). This expansion reflects growing clinical adoption of novel targeted therapies and increasing healthcare investments in...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
rohit001 added blog Literature
2026-06-24 06:25:12

SERD (Selective Estrogen Receptor Degrader) Drug Market Advances with Expanding Breast Cancer Research and Next-Generation Hormone Therapy Innovations
According to the latest report published by Data Bridge Market Research, the SERD (Selective Estrogen Receptor Degrader) Drug Market The global SERD (Selective Estrogen Receptor Degrader) drug market size was valued at USD 2.84 billion in 2025 and is expected to reach USD 8.93 billion by 2033, at a CAGR of 15.40% during the forecast period The persuasive SERD (Selective Estrogen...

0 Comments 0 Shares 413 Views 0 Reviews

Please log in to like, share and comment!